Cheapest Mounjaro 2026: $1,200/mo (Oak) vs $1,249/mo (TrimRx)
Mounjaro is FDA-approved tirzepatide for type 2 diabetes. Only 2 telehealth clinics offer it — Oak at $1,200/mo and TrimRx at $1,249/mo. Compounded tirzepatide starts at $149/mo.
Cheapest Mounjaro Prices in 2026: Both Telehealth Providers
Prices verified April 2026. Year 1 Cost assumes 12 months at the listed price.
| Provider | Medication | Monthly Price | Year 1 Cost | Notes | Get Started |
|---|---|---|---|---|---|
| Oak ★★★★★4.6 | Mounjaro BRAND NAME | $1,200/mo | BEST PRICE$14,400 | Get Started → | |
| TrimRx ★★★☆☆3.3 | Mounjaro BRAND NAME | $1,249/mo | $14,988 | Get Started → |
Prices verified April 2026. Mounjaro is FDA-approved for type 2 diabetes; off-label weight-loss use requires provider discussion. Full disclaimer ↓
Better Alternatives to Mounjaro for Weight Loss
Mounjaro costs $14,400–$14,988/year and is approved for diabetes, not weight loss. Two better options exist for most patients.
Compounded Tirzepatide
- Same active ingredient, from $149/mo ($1,788/yr)
- Prescribed for weight loss — no off-label issue
- Available at Gala, PeterMD, Oak, TrimRx, and more
- Legally available while brand-name is on shortage list
Brand-Name Zepbound
- Same molecule as Mounjaro (tirzepatide)
- FDA-approved for weight loss — not off-label
- Shed offers it at $474/mo effective ($5,688/yr)
- Still cheaper than Mounjaro at $14,400–$14,988/yr
About Mounjaro
Active Ingredient
Tirzepatide — same molecule as Zepbound. Targets both GLP-1 and GIP receptors, producing ~22% average weight loss in clinical trials.
FDA Approval
Approved May 2022 for type 2 diabetes management. Zepbound (same molecule) was approved November 2023 specifically for weight loss.
Retail Price
Without insurance, Mounjaro retails at approximately $1,060/month at major pharmacies — $12,720/year. Telehealth providers charge more.
Insurance Coverage
Often covered for type 2 diabetes with prior authorization. Coverage for off-label weight loss use is typically denied. Medicare excludes weight-loss drugs.
See how all 13 GLP-1 clinics — including compounded options starting at $149/mo — compare side by side.
Compare All 13 GLP-1 Clinics →Cheapest Mounjaro 2026: FAQ
Oak offers brand-name Mounjaro at $1,200/month ($14,400/year) — the cheapest telehealth price in 2026. TrimRx charges $1,249/month ($14,988/year). Compounded tirzepatide (same active ingredient) starts at $149/month ($1,788/year) through Gala — about 8× cheaper.
Yes — Mounjaro and Zepbound both contain tirzepatide, the exact same active ingredient made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes (2022); Zepbound is FDA-approved for weight loss (2023). For weight loss specifically, Zepbound is the appropriate indication. Shed offers brand-name Zepbound at $474/month effective. See Zepbound prices →
Mounjaro is FDA-approved only for type 2 diabetes. Providers may prescribe it off-label for weight management, but Zepbound (same molecule, weight-loss indication) is a more straightforward choice for weight loss. For the cheapest tirzepatide for weight loss, compounded tirzepatide from Gala starts at $149/month.
Two options beat Mounjaro on price: (1) Compounded tirzepatide from Gala at $149/month ($1,788/year) — 8× cheaper, same active ingredient. (2) Brand-name Zepbound through Shed at $474/month effective ($5,688/year) — still 2.5× cheaper than Mounjaro and properly indicated for weight loss. Compare all compounded tirzepatide options →
⚕ Medical & Legal Disclaimer
Not Medical Advice. AffordableGLPs.com is an independent price comparison site. All content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting any GLP-1 medication.
Affiliate Disclosure. Some links on this page are affiliate links. We may earn a commission when you purchase through our links, at no additional cost to you.
Pricing Accuracy. Prices are audited periodically and may change without notice. Confirm current pricing on the clinic's website before purchasing. Last Price Audit: April 2026